RNXT
RenovoRx (RNXT)
$84
About RenovoRx (RNXT)
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in 2009 and is headquartered in Mountain View, CA.
Details
Daily high
$0.97
Daily low
$0.83
Price at open
--
52 Week High
$1.69
52 Week Low
$0.70
Market cap
30.9M
Dividend yield
0.00%
Volume
120
Avg. volume
213,269
P/E ratio
-2.37
RenovoRx News
Details
Daily high
$0.97
Daily low
$0.83
Price at open
--
52 Week High
$1.69
52 Week Low
$0.70
Market cap
30.9M
Dividend yield
0.00%
Volume
120
Avg. volume
213,269
P/E ratio
-2.37